{"_id":"agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4MTurMEIDA","lastupdate":"2024-05-23T00:00:00.000Z","update_date":"2024-05-23T00:00:00.000Z","lastModified":"Jan 6, 2026","active":1,"confidence_score":98,"confidence_score_reason":"markets","urlname":"regenyx-medical","minimal_profile":null,"status":"","fullstatus":"","acquired":0,"hide_reason":null,"hide_reason_data":null,"hide_reasons":[{"id":"8257rxn4P8EFQOmS5hAAauHyYMhhxrA5u6yWX4XUShpybX3AMNo3Y9","reason":"Pending approval - External entity"},{"id":"aOIaOiiqfpA8UMw6VCTh8ueRmkG3lzDy1NGqEOaJbe11OrCzMTCCd6","reason":"The company is a service provider"},{"id":"ddgjKuc3GgH8E5UehSVJviRl471BCajL1plO8HtGoOojy2NivYqQ7x","reason":"Owner asked to delete"},{"id":"EjOKM211H1ira9J63oaGPuUxvr7Oba55TZo3NWsFO5uhbNu7o4x4zD","reason":"The company is not Israeli"},{"id":"J7fQJtnT3GdWWSE3MD8rzaW65LJ4jEIKxSZnneQiReONdZjG3zIqWe","reason":"Owner asked to hide in the meantime"},{"id":"NxlAC3ReFb5ksiYNLp2FnUyluoJzwRCYfcF7xpTZaPM53SdWQ5kv0B","reason":"Pending approval"},{"id":"RhC1tlwXzioK0MfzBII3H2wepEfQOfKVktmdwqeqTJjGi3ZaBWUqZo","reason":"The company is not innovative"},{"id":"S0Ed46vNI6vZYVxLedANWGjas23K6hY0QdsCtiGYL7lshqIEdLV3sA","reason":"The company ceased operations in Israel"},{"id":"VTANq7bEvlsEcPjp0ghelXfShaCosgndONGjgU730aAOxXtaDIF5j3","reason":"This is a product of an existing company"}],"type":"Startup","logokey":"$AO3ruelbf6O6K066w9YsOD7FWTNbVUObnue0XvbTZ3QsrparjA5FLW.png","name":"Regenyx Medical","oneliner":"Regenyx is redefining soft tissue restoration with matrix-enhanced fat grafting","registrar":"515544682","website":"https://regenyxmed.com/","careerspage":"","founded_month":11,"founded_year":2016,"formernames":["Bone Sci. Bio Ltd."],"sociallinks":{"twitter":"","youtube":"","facebook":"","linkedin":"https://www.linkedin.com/company/102185269","instagram":""},"social":["https://www.linkedin.com/company/102185269"],"flattenedsociallinks":"https://www.linkedin.com/company/102185269","apps":{"appstore":"","googleplay":""},"is_claimed_by_owner":1,"employees":"1-10","employees_exact":6,"patent":1,"raised":3400000,"stage":"Seed","public_stage":"Seed","primary_sector_key":"agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","primary_sector":"Health Tech & Life Sciences","alternativenames":["Bonsay","Bone-Sci-Bio","Bone-Sci","Bonsai","BoneSci","BoneSciBio"],"about":"Regenyx Medical is redefining minimally invasive soft tissue restoration—a cornerstone of plastic and reconstructive surgery. Our lead product, Lipogenyx, is the first fat viability extender: a next-generation fat grafting solution that enhances graft survival and integration, enabling natural-looking, lasting and predictable results in reconstructive and aesthetic procedures. Built on a proprietary synthetic peptide hydrogel technology, Lipogenyx offers a scalable, potentially reimbursable platform that eliminates the need to revision fat grafting procedures and streamlines physicians efficiency and patient satisfaction. Selected for the 2025 MedTech Innovator and ASPS Top 5 Innovation Track, Regenyx is now preparing for its first clinical study and establishing U.S. operations.","climatetech_description":null,"is_climatetech_relevant":null,"phone":"+972-545223489","country":null,"address":{"israeli":[{"id":"e5a6b2a3-2437-472d-9770-c64a3340a3ef","city":"Rehovot","type":null,"address":"Prof. A. D. Bergman St 2, Rehovot, Israel","placeid":"ChIJk9kY_Vq3AhURxTACQJ8Vj8k","notactive":0,"openeddate":null,"registrarid":null,"firstrdcenter":0,"registrarname":null}],"officesabroad":null},"headquarter_address":null,"district":"Center District","news":[{"id":"TrjHndRhFzP2MAeiIVhCjyalDrBHTdBRan4W5YLBqiWikLjTGyCifH","date":"Jun 13, 2025","link":"https://www.plasticsurgery.org/news/press-releases/five-plastic-surgery-startups-selected-for-mti/asps-plastic-surgery-accelerator-competition-finals","source":"www.plasticsurgery.org","visible":1,"analysis":{"tags":"innovation","round":null,"company":"MedTech Innovator","layoffs":null,"summary":"MedTech Innovator, in partnership with the American Society of Plastic Surgeons (ASPS), has advanced five startups as finalists in the 2025 MedTech Innovator competition. These startups, which focus on medical device, diagnostic, and digital health technology, will compete for a share of $800,000 in funding awards. The program aims to foster innovation in plastic surgery by providing mentorship and support to early-stage companies. The finalists will be featured at an upcoming event in New Orleans and will receive guidance from ASPS surgeons and industry leaders. MedTech Innovator has a history of supporting over 500 companies, resulting in significant FDA approvals and funding.","partners":["American Society of Plastic Surgeons"],"customers":null,"eventType":null,"investors":null,"confidence":9,"key_topics":["startups","plastic surgery","mentorship","funding","innovation"],"date_of_event":"2025","product_stage":"R&D","investment_date":null,"acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Partners"],"acquisition_amount":null,"FDA approved/pending approval":"pending approval","AI technology developing/using":null,"structuredIssuesShow":"#Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"2QLxA0cEIrbEXkIuBZPnRDkvKMkxzi9jq7XSUgXKVBHAWBGREtOuLz","news_summary":"Five Plastic Surgery Startups Selected for MTI/ASPS Plastic Surgery Accelerator Competition Finals","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"a7xeBULBBYq7qMVY4QQwWmEXSZVfQSlMI8UF8i9uqpTgqXJ7jVweRd","date":"Jun 5, 2025","link":"https://medtechinnovator.org/medtech-innovator-unveils-64-breakthrough-medtech-startups-in-its-2025-cohort/","source":"medtechinnovator.org","visible":1,"analysis":{"tags":"accelerator program","round":null,"company":"MedTech Innovator","layoffs":null,"summary":"MedTech Innovator (MTI), the worlds largest accelerator for medical technology startups, announced its 2025 Accelerator Cohort, selecting 64 companies from nearly 1,500 global applicants. These companies will participate in a four-month program offering mentorship, strategic guidance, and access to MTIs ecosystem of industry leaders. The cohort includes early and mid-stage medical device, diagnostic, and digital health companies competing for $800,000 in non-dilutive funding. MTIs program aims to de-risk innovation and accelerate U.S. market success. The accelerator includes specialty tracks in partnership with the American Society for Plastic Surgeons and the American Heart Association. MTIs founding sponsors include Johnson & Johnson MedTech and Research Corporation Technologies, with additional support from various industry leaders.","partners":["American Heart Association","American Society of Plastic Surgeons","AdvaMed","DeviceTalks","Health+Commerce","MedTech Strategist","Wilson Sonsini"],"customers":null,"eventType":null,"investors":["Johnson & Johnson MedTech","Research Corporation Technologies","Asahi Intecc","Becton Dickinson and Company","Dexcom","Edwards Lifesciences","NIPRO Medical","Olympus Corporation of the Americas","W. L. Gore & Associates","Zimmer Biomet","Andrews Cooper","BioT Medical","Cambridge Consultants","Canon Quality Group","Medmarc","Minnetronix Medical","PDV MedTech","ProLucid Technologies","PRIA Healthcare","Proxima Clinical Research","RegNav","Siemens","Veeva Systems","Velentium","Veranex"],"confidence":9,"key_topics":["accelerator","funding","mentorship","innovation","healthcare"],"date_of_event":"June 5, 2025","product_stage":"early and mid-stage","investment_date":"June 5, 2025","acquired_company":null,"valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":"$800,000","structured_issues":[],"acquisition_amount":null,"FDA approved/pending approval":null,"AI technology developing/using":null,"entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"96b1M11A5ksMBiLovgAcClpFvsPXLk5T3ioVdXvuXBaJfUW9C4h9Rk","news_summary":"MedTech Innovator Unveils 64 Breakthrough Medtech Startups in its 2025 Cohort - MedTech Innovator","analysisStructuredIssuesDisplay":"none","analysisImpactOnCompanyDisplay":"block"},{"id":"47f48fd8-1e42-4cc1-be7b-524e033f0180","date":"May 15, 2019","link":"https://in.bgu.ac.il/en/bgn/pages/news/bonescibio.aspx","source":"in.bgu.ac.il","visible":1,"analysis":{"tags":"bone treatment","company":"Bone Sci Bio","layoffs":null,"summary":"Bone Sci Bio introduces PeptOss, a novel solution for bone treatment that promotes bone regeneration and enables controlled drug delivery. The company will present its product at the MIXiii-BIOMED 2019 Conference and Exhibition. PeptOss has various applications in orthopedic and dental medicine, including treating peri-implantitis and strengthening osteoporotic bones. The technology was patented by BGN Technologies. In pre-clinical trials, PeptOss has shown promising results, outperforming the control by up to 80%. Bone Sci Bio aims to gain FDA approval and address the unmet need in peri-implantitis treatment.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["PeptOss","bone treatment","orthopedic and dental applications","drug delivery","peri-implantitis"],"date_of_event":"May 14, 2019","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers","Partners"],"acquisition_amount":null,"structuredIssuesShow":"#Customers  #Partners","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"xsr7L7oQ06IEp6npPUKZOHex1P9gmsyjH3H85iWHorbkoDczym1kJO","news_summary":"Bone Sci Bio Presents Breakthrough Solutions for Bone Healing","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"},{"id":"2148f735-9f47-4d3f-89ed-c4beeead2423","date":"May 14, 2019","link":"https://www.timesofisrael.com/israeli-startup-seeks-to-boost-bone-renewal-and-allow-targeted-drug-delivery/?utm_source=Startup+Daily&utm_campaign=startup-daily-2019-05-14&utm_medium=email","source":"www.timesofisrael.com","visible":1,"analysis":{"tags":"bone treatment","company":"Bone Sci Bio Ltd.","layoffs":null,"summary":"Israeli startup Bone Sci Bio Ltd. is developing PeptOss, a product that promotes bone formation and repair while enabling controlled drug delivery. The product has applications in orthopedic and dental medicine, including the treatment of peri-implantitis and osteosarcoma. PeptOss is made up of a proprietary peptide that mimics bone proteins and self-assembles as a hydrogel. The technology has shown promising results in pre-clinical trials. The company estimates the bone substitute market to be worth $4.5 billion. Clinical studies and FDA approval are still pending.","partners":null,"customers":null,"investors":null,"confidence":8,"key_topics":["Bone treatment","PeptOss","Drug delivery","Orthopedic medicine","Dental medicine"],"date_of_event":"May 14-16, 2019","valuation_amount":null,"impact_on_company":"growth-positive","investment_amount":null,"structured_issues":["Customers"],"acquisition_amount":null,"structuredIssuesShow":"#Customers","entityGrowthIconPath":"url(/assets/circle-green.svg);"},"sentiment":"growth-positive","analysisId":"YCifQVcBQDjAK0DEuKWymqca6TO32c8cfNofKRShXkUr3kenKJaF9S","news_summary":"Israeli startup seeks to boost bone renewal and allow targeted drug delivery","analysisStructuredIssuesDisplay":"block","analysisImpactOnCompanyDisplay":"block"}],"newsNumber":4,"techcommunityinvolvement":null,"mediagallery":[{"id":"9QFezMgXLYfeoIVXMQUW6WWaHM7Qytwp8MaA1Chj7lhRod3MeXZUAc","timestamp":"2025-10-23 10:42:56.000000","resources_type":1,"resources_title":"Regenyx wall cover","resources_file_name":"$uhWzgcEEGaJuYtLg9oWP817J1EI7o6eAmLkTzAiMeSuL85qWiNrFfr.jpeg","alt":"Regenyx wall cover logo","cleanBucketUrl":"https://storage.googleapis.com/clean-finder-353810","imageurl":"https://storage.googleapis.com/clean-finder-353810/$uhWzgcEEGaJuYtLg9oWP817J1EI7o6eAmLkTzAiMeSuL85qWiNrFfr.jpeg","url":"https://storage.googleapis.com/clean-finder-353810/$uhWzgcEEGaJuYtLg9oWP817J1EI7o6eAmLkTzAiMeSuL85qWiNrFfr.jpeg"},{"id":"wCGCztj3SbjSv9tEjTL0UC2TpJZCN0H5wfYvfm7OO0jZcgwcOtQkTQ","timestamp":"2025-10-23 10:42:55.000000","resources_type":2,"resources_title":"Lipogenyx by Regenyx","resources_file_name":"2tvMGk9tLGU","alt":"Lipogenyx by Regenyx logo","imageurl":"https://img.youtube.com/vi/2tvMGk9tLGU/0.jpg","url":"http://youtu.be/2tvMGk9tLGU"}],"tags":["biopharmaceutical","chronic-patients","degenerative-diseases","treatments","tissue-regeneration","bone","orthopedics","osteoporosis","regenerative-medicine","inflammatory-diseases","sustained-release","drug-delivery","pharmaceuticals","dental","peptides"],"classificationIDs":["agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4MeNluQIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gKDA"],"technologysuccessstory":null,"usecases":[],"businessmodels":["B2B"],"productstage":"Clinical Trial","products":["Allogenyx","Lipogenyx"],"geomarkets":["Global"],"targetmarkets":[],"marketcapital":null,"marketcapitaldate":null,"funding":{"investors":2,"lastfunding":"$1.4M","totalrounds":3,"fundingstage":"Seed","totalfunding":"$3.4M","publicinvestors":2,"lastpublicfunding":1400000,"totalpublicrounds":3,"totalpublicfunding":3400000},"team":[{"name":"Yaron Rapaport","email":"yaronrap@gmail.com","phone":"0545223489","gender":"Male","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoJ2a88wIDA","bounced":false,"claimed":1,"founder":1,"urlname":"yaron-rapaport-2","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDg5K-4ywgM","position":"Founder & CEO","last_name":"Rapaport","claimtoken":"3747f4ed42291328767b865639d97031ffd26e95a03cdfadabd389fd0ced5623","first_name":"Yaron","picturekey":"$vM8eUfkGX7hZGolRaEXmfkKzvuNWON1MZqYvMrFa7dwEbXECkx8wUn","claimeddate":"2019-05-19","linkedinurl":"https://www.linkedin.com/in/rapaport-yaron-1100704/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2019-05-19 06:01:40.000000","initials":"","pictureurl":"https://storage.googleapis.com/clean-finder-353810/$vM8eUfkGX7hZGolRaEXmfkKzvuNWON1MZqYvMrFa7dwEbXECkx8wUn","linkedin-display":"flex","teammembertagclass":"connect","teammembertagcontent":"Connect","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Prof. Hanna Rapaport","email":"hannarapaport@regenyxmed.com","phone":"","gender":"Female","userid":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICA4MTHv9wIDA","bounced":true,"claimed":0,"founder":1,"urlname":"prof-hanna-rapaport","visible":1,"memberid":"agxzfmlsbGlzdHNpdGVyFwsSCk5ld19NZW1iZXIYgIDgpIuxwAkM","position":"Founder, Inventor & CSO","last_name":"Rapaport","claimtoken":"XqlThUpBu050t8ir07KtjmeESCyMtmmwWkoauNTKMaqssv6yk5dTw6","first_name":"Prof. Hanna","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/hanna-rapaport-34460b4b/","unsubscribed":false,"is_activeuser":1,"additionalemail":"","claimedemaildate":"2024-05-23 13:10:42.000000","initials":"PR","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Dr. Itay","email":"","phone":"","gender":null,"userid":"J56TnQSzxGnD6VmZ7wE8iRmUamce84B31nvO7vWVTFCjqhYQy2wye3","bounced":false,"claimed":null,"founder":0,"urlname":"dr-itay","visible":1,"memberid":"1L5kPjPSX3uNmE69Xz6s4XJt3SHxFTr3ZQ19A3YICBpJuX46nIyiXH","position":"CMO - USA","last_name":"Itay","claimtoken":null,"first_name":"Dr.","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/itay-wiser-b5528228/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":null,"initials":"DI","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Itay Wiser","email":"","phone":"","gender":null,"userid":"oonEMQAHCFAEzuKQLknruNKzwdLfqERjEBBwlclxgxc8Wf7fkHYp7U","bounced":false,"claimed":null,"founder":0,"urlname":"itay-wiser","visible":1,"memberid":"daG3o3jUnnCsGLlNAcIX2eUTo5hIfa9BJcZRIL8JGa0gRgF43cnmot","position":"CMO - USA","last_name":"Wiser","claimtoken":null,"first_name":"Itay","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/itay-wiser-b5528228/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":null,"initials":"IW","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Zvika Blutstein","email":"","phone":"","gender":null,"userid":"oJCJc7EpZ5Sx9oZzbtilvp4l4Ro2xUDQAudLQvks4DJMbyKIRA1nSv","bounced":false,"claimed":null,"founder":0,"urlname":"zvika-blutstein-2","visible":1,"memberid":"eIskEvfCr0qyOIKSiCkTQOmk17X7XwTDz1v03cZU0Nh2c93ZthZpHy","position":"COO","last_name":"Blutstein","claimtoken":null,"first_name":"Zvika","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/zvikablutstein/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":null,"initials":"ZB","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""},{"name":"Nadav  Orr","email":"nadav@regenyxmed.com","phone":"","gender":"Male","userid":"YXOedq1ZDMYOB0v6mGOHRyMWHoHpaLvBJKDXqjyggxfNVK8cmtQiEu","bounced":true,"claimed":null,"founder":0,"urlname":"nadav-orr-1","visible":1,"memberid":"KwyvPBeBK7NRmcNAU2aJrSb6yaKPeyhZ4LnRCKagE8Y8INGrbNo0QR","position":"CTO","last_name":"Orr","claimtoken":"0FgGD2yXvmudwRK7aFnm2rEJGkDLLl168qMHyGXlEwkZr9mVrDznon","first_name":"Nadav ","picturekey":null,"claimeddate":null,"linkedinurl":"https://www.linkedin.com/in/nadav-orr-564a4345/","unsubscribed":false,"is_activeuser":0,"additionalemail":"","claimedemaildate":"2024-05-23 13:10:25.000000","initials":"NO","pictureurl":"/assets/empty-state.svg","linkedin-display":"flex","teammembertagclass":"none","teammembertagcontent":"","channelId":"","visibilityClassName":"","visibilityTooltip":""}],"description_edited":1,"tag_line_edited":1,"sector":"Pharmaceuticals","sectorverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAoPW8rMQKDA","fullname":"Lena Rogovin"},"biverify":{"id":"agxzfmlsbGlzdHNpdGVyFQsSCE5ld19Vc2VyGICAwN25h58KDA","fullname":"Vered Waxman"},"biverifydate":"2020-02-16T00:00:00.000Z","crunchbaseid":"bone-sci-bio","lastupdator":"Yanina Wainscheinker","lastupdator_email":"yanina.wainscheinker@sncentral.org","creator":"Yotam Maman","creator_email":"yotamm1988@gmail.com","createdate":"2019-05-16T00:00:00.000Z","biverification":"Vered Waxman","sectorverification":"Lena Rogovin","affiliatedOrganizations":null,"timeline":[{"id":"go2XQ453ULIJ38M3waqPdOisqK3RfkwH00ZcBzov44cuzxWCvqCG8W","date":"Jul 2023","amount":"$1.4M","source":"","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":1400000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"PN3QK4J6QREuSdRhLPuDurcLQvFi7vbCJBZJjzar8SQEKBtfXvRBVB","date":"Feb 2021","amount":"$1M","source":"","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":1000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODEvsKECQw","date":"May 2019","amount":"$1M","source":"From the founder","eventtype":"FundingRoundEvent","investment":[{"name":"Israel Innovation Authority","type":"Government","amount":0,"hidden":false,"country":"Israel","fullurl":"/company_page/israel-innovation-authority-4","logokey":"$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","tagline":"","urlname":"/company_page/israel-innovation-authority-4","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC20eTwCQw","fundingtype":"Government","leadpartner":null,"investmentid":"46b3aee3-f889-44ad-9fad-da8f17074a5e","fundingsubtype":"","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","leadcaption":"Lead ","followupcaption":""},{"name":"Undisclosed Investor(s)","type":"Investor","amount":0,"hidden":true,"country":"Unknown location","fullurl":"/investor_page/undisclosed-investor-s","logokey":null,"tagline":"","urlname":"/investor_page/undisclosed-investor-s","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE3L3CCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"e78fbe36-8be3-4a6e-bcc8-1205905b5236","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"Lead ","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":1000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"investmentstage":[],"exits":[],"investments":[],"portfolio":[],"funds":[],"founded":"11/2016","databases":[],"sharedspaces":[],"utilities":[],"contributors":[],"employeesworldwide":"","fundingtype":"Startup","parsedName":"Regenyx Medical","logourl":"https://storage.googleapis.com/clean-finder-353810/$AO3ruelbf6O6K066w9YsOD7FWTNbVUObnue0XvbTZ3QsrparjA5FLW.png","oglogourl":"https://storage.googleapis.com/clean-finder-353810/$AO3ruelbf6O6K066w9YsOD7FWTNbVUObnue0XvbTZ3QsrparjA5FLW.png","seoabout":"Regenyx Medical is redefining minimally invasive soft tissue restoration—a cornerstone of plastic and reconstructive surgery. Our lead product, Lipogenyx, ...","seoTitle":"Israeli Startup","solutions":[],"teamMembersNumber":6,"primarySector":"Health Tech & Life Sciences","primary-sector-display":"block","classifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Biomaterials & Tissue Engineering","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4MeNluQIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drug Delivery","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gKDA","classificationName":"sectorclassification"},{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Materials & Substances","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","classificationName":"coretechnology"},{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"}],"classificationDelimited":["SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Biomaterials & Tissue Engineering#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4MeNluQIDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","TechnologyClassificationModel>Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA>Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA>Drug Delivery#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gKDA"],"classificationsViewModel":"|0:>SectorClassificationModel|1:>SectorClassificationModel/Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA|2:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA/Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Biomaterials & Tissue Engineering#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4MeNluQIDA|3:>SectorClassificationModel>Health Tech & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA>Pharma & Medical Biotechnology#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA/Drug Delivery#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gKDA|0:>IndustryClassificationModel|1:>IndustryClassificationModel/Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Providers#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA|3:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA>Healthcare#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA/Patients#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA|2:>IndustryClassificationModel>Healthcare & Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA/Life Sciences#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA|0:>TechnologyClassificationModel|1:>TechnologyClassificationModel/Materials & Substances#agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA|","classificationTrees":{"sector":[{"title":"Health Tech & Life Sciences","key":"0-0","path":"SectorClassificationModel>Health Tech & Life Sciences","children":[{"title":"Pharma & Medical Biotechnology","key":"0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology","children":[{"title":"Biomaterials & Tissue Engineering","key":"0-0-0-0","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Biomaterials & Tissue Engineering"},{"title":"Drug Delivery","key":"0-0-0-1","path":"SectorClassificationModel>Health Tech & Life Sciences>Pharma & Medical Biotechnology>Drug Delivery"}]}]}],"targetCustomer":[{"title":"Healthcare & Life Sciences","key":"0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences","children":[{"title":"Healthcare","key":"0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare","children":[{"title":"Providers","key":"0-0-0-0","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Providers"},{"title":"Patients","key":"0-0-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Healthcare>Patients"}]},{"title":"Life Sciences","key":"0-0-1","path":"IndustryClassificationModel>Healthcare & Life Sciences>Life Sciences"}]}],"coreTechnology":[{"title":"Materials & Substances","key":"0-0","path":"TechnologyClassificationModel>Materials & Substances"}]},"sectorClassifications":[{"depth":0,"name":"Sector","queryString":"sectorclassification=undefined","classificationName":"sectorclassification"},{"depth":1,"name":"Health Tech & Life Sciences","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LuwgtgKDA","classificationName":"sectorclassification"},{"depth":2,"name":"Pharma & Medical Biotechnology","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Lu-rdMJDA","classificationName":"sectorclassification"},{"depth":3,"name":"Biomaterials & Tissue Engineering","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4MeNluQIDA","classificationName":"sectorclassification"},{"depth":3,"name":"Drug Delivery","queryString":"sectorclassification=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Kv1r_gKDA","classificationName":"sectorclassification"}],"coreTechnologyClassifications":[{"depth":0,"name":"Core Technology","queryString":"coretechnology=undefined","classificationName":"coretechnology"},{"depth":1,"name":"Materials & Substances","queryString":"coretechnology=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4IfeyKYIDA","classificationName":"coretechnology"}],"targetCustomerClassifications":[{"depth":0,"name":"Target Customer","queryString":"targetcustomer=undefined","classificationName":"targetcustomer"},{"depth":1,"name":"Healthcare & Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4If8nsIKDA","classificationName":"targetcustomer"},{"depth":2,"name":"Healthcare","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4Puah5IIDA","classificationName":"targetcustomer"},{"depth":3,"name":"Providers","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4JvZ7tMLDA","classificationName":"targetcustomer"},{"depth":3,"name":"Patients","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4PuD2a4JDA","classificationName":"targetcustomer"},{"depth":2,"name":"Life Sciences","queryString":"targetcustomer=agxzfmlsbGlzdHNpdGVyJAsSF0Jhc2VDbGFzc2lmaWNhdGlvbk1vZGVsGICA4LunvfsLDA","classificationName":"targetcustomer"}],"classificationNames":{"sector":["Health Tech & Life Sciences","Pharma & Medical Biotechnology","Biomaterials & Tissue Engineering","Drug Delivery"],"coreTechnology":["Materials & Substances"],"targetCustomer":["Healthcare & Life Sciences","Healthcare","Providers","Patients","Life Sciences"]},"section":null,"sectionParams":"","queryParams":"","popup_claim_profile":"false","claimedBadge":"inline","display":{"mainContact":"none","climateTag":"none","seeMoreSimilarCompanisDisplay":"none","similarCompaniesTitleFontSize":"3.2rem","similarCompaniesTitle":"Similar Companies","similar_companies":[]},"mainContact":{},"_eventview":{"publicoffering_exit":[],"privateequityfunding":[{"id":"go2XQ453ULIJ38M3waqPdOisqK3RfkwH00ZcBzov44cuzxWCvqCG8W","date":"Jul 2023","amount":"$1.4M","source":"","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","style":"","hiddenCompanyTooltip":"","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","sectionname":"Private Equity Funding","amountnumber":1400000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"PN3QK4J6QREuSdRhLPuDurcLQvFi7vbCJBZJjzar8SQEKBtfXvRBVB","date":"Feb 2021","amount":"$1M","source":"","eventtype":"FundingRoundEvent","investment":[],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":1000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"},{"id":"agxzfmlsbGlzdHNpdGVyFgsSCUJhc2VFdmVudBiAgODEvsKECQw","date":"May 2019","amount":"$1M","source":"From the founder","eventtype":"FundingRoundEvent","investment":[{"name":"Israel Innovation Authority","type":"Government","amount":0,"hidden":false,"country":"Israel","fullurl":"/company_page/israel-innovation-authority-4","logokey":"$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","tagline":"","urlname":"/company_page/israel-innovation-authority-4","isisraeli":1,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOC20eTwCQw","fundingtype":"Government","leadpartner":null,"investmentid":"46b3aee3-f889-44ad-9fad-da8f17074a5e","fundingsubtype":"","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"https://storage.googleapis.com/clean-finder-353810/$5c4LgWLzukZDi2b9IlcK1cbez0QSOoXpTLU21Y4ByNtfkRvqOSLs8L","leadcaption":"Lead ","followupcaption":""},{"name":"Undisclosed Investor(s)","type":"Investor","amount":0,"hidden":true,"country":"Unknown location","fullurl":"/investor_page/undisclosed-investor-s","logokey":null,"tagline":"","urlname":"/investor_page/undisclosed-investor-s","isisraeli":0,"investorid":"agxzfmlsbGlzdHNpdGVyHAsSD0V4dGVybmFsX0VudGl0eRiAgOCE3L3CCgw","fundingtype":"VC and Private Equity","leadpartner":null,"investmentid":"e78fbe36-8be3-4a6e-bcc8-1205905b5236","fundingsubtype":"VC and Private Equity","investorislead":1,"amountvisibility":"Public","isextensionround":0,"leadpartneruserid":null,"investorisfollowon":0,"investorvisibility":"Public","leadpartnermemberid":null,"investmentVisibilityClassName":"","investmentVisibilityTooltip":"","blurFinancialData":"","style":"","hiddenCompanyTooltip":"","logourl":"/assets/investors-icon.svg","leadcaption":"Lead ","followupcaption":""}],"eventvisibility":"Public","amountvisibility":"Public","fundingvisibility":"Public","fundingtypefundingtype":"Seed","fundingvisibilityClassName":"","fundingvisibilityTooltip":"","amountvisibilityClassName":"","amountvisibilityTooltip":"","token_visibilityClassName":"","token_visibilityTooltip":"","style":"","hiddenCompanyTooltip":"","sectionname":"Private Equity Funding","amountnumber":1000000,"capitalraised":"Undisclosed","valuation":"Undisclosed"}],"nonequityfunding":[],"merger_acquisitions":[],"others":[]}}